Developer of AI-based diagnostic tests designed to support precision oncology and biomarker-driven medicine. The company applies machine learning and foundation models to histopathology and multimodal clinical data, offering AI-enabled biomarker discovery, risk and outcome prediction, treatment-response assessment, and workflow integration with pathology and oncology systems, enabling healthcare providers and biopharmaceutical companies to conduct scalable, data-driven testing that supports targeted therapies, clinical decision-making, and streamlined diagnostic pathways across oncology.